Delivery Order SPE2DB22D1202-SPE2DB25FUPK6

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB24D3015|SPE2DB25FFWVQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, with an ultimate completion date of October 30, 2024 and a ceiling value of $20,630.92. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated...
This federal contract award, with a value of $26,803.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for TALTZ 80 MG/ML AUTOINJECTOR, a pharmaceutical product, with a performance period through December 15, 2023. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TALTZ 80 MG/ML AUTOINJECTOR medication. The contract is a Firm Fixed Price Delivery Order valued at $9,642.38, with an ultimate completion date of October 13, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $4,452.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a medication, with a period of performance through January 3, 2025. The contract is a delivery order with a firm fixed price structure. This award is not associated with a set-aside program. Amerisourcebergen holds a significant...
This federal contract award, with ID SPE2DB22D3010|SPE2DB24FP2KA, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has a ceiling value of $15,702.51 and is a Firm Fixed Price Delivery Order with a completion date of May 15, 2024. The contract was awarded on May 14, 2024 and does not have a set-aside designation, indicating open...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY7VS, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $53,510.87. It is a firm fixed price delivery order contract, with a period of performance through June 4, 2024. The contract does not have a set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,850.79 firm fixed price delivery order is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award, valued at $14,663.57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corp. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications,...
This federal contract award, valued at $23,535.80, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The delivery order is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of October 16, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp, a for-profit organization and major pharmaceutical distributor, will provide these medical products to support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,688.79 contract is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The delivery order contract has a firm fixed price pricing type and runs through October 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUPK6
    Delivery Order

This federal contract award, identified as SPE2DB22D1202|SPE2DB25FUPK6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, under a Firm Fixed Price Delivery Order contract type. The contract has a ceiling value of $17,726.16 and an ultimate completion date of January 14, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 9:45 AM